Home » Stocks » STVN

Stevanato Group S.p.A. (STVN)

Stock Price: $19.90 USD -0.10 (-0.50%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Market Cap 5.82B
Revenue (ttm) 820.56M
Net Income (ttm) 123.36M
Shares Out 292.43M
EPS (ttm) 0.42
PE Ratio 47.17
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 27
Last Price $19.90
Previous Close $20.00
Change ($) -0.10
Change (%) -0.50%
Day's Open 20.20
Day's Range 19.47 - 20.24
Day's Volume 682,728
52-Week Range 16.61 - 20.74

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Stevanato Group makes NYSE debut

YouTube video

Franco Stevanato joins 'The Exchange' to speak about his company's NYSE debut today. The Stevanato Group makes glass vials and other components critical to distributing Covid-19 vaccines.

1 week ago - CNBC Television

(Reuters) -Shares of Italy's Stevanato Group S.p.A., which makes glass vials for COVID-19 vaccines and other healthcare products, fell more than 20% in their New York Stock Exchange debut, giving the co...

1 week ago - Reuters

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (the “Company”) today celebrates its debut on the New York Stock Exchange under the ticker symbol “STVN.” Founded by Giovanni Stevanato in 1...

1 week ago - Business Wire

Stevanato Group S.p.A., an Italian maker of glass vials for COVID-19 vaccines and other healthcare products, raised $672 million in a downsized initial public offering on Thursday.

1 week ago - Reuters

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology ...

1 week ago - Business Wire

Stevanato Group S.p.A. (the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced...

2 weeks ago - Business Wire

Italy's Stevanato Group, manufacturer of glass vials for COVID-19 vaccines and other healthcare products, filed for a U.S. initial public offering on Monday, as the pandemic boosted the demand for some ...

1 month ago - NASDAQ

Stevanato Group S.p.A. (the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today ann...

1 month ago - Business Wire

Stevanato Group S.p.A. has filed to go public with an IPO on the New York Stock Exchange (NYSE).

1 month ago - SEC

About STVN

Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. We deliver an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Our core capabilities in scientific research and development, our commitment to technical innovation and our engineering excellence are central to our ability to offer value... [Read more...]

Industry
Glass Containers
IPO Date
Jul 16, 2021
CEO
Franco Moro
Employees
4,344
Stock Exchange
NYSE
Ticker Symbol
STVN
Full Company Profile

Financial Performance

In 2020, STVN's revenue was 662.04 million, an increase of 23.39% compared to the previous year's 536.54 million. Earnings were 78.51 million, an increase of 100.28%.

Financial numbers in millions EUR.
Financial Statements